Dr. Samuel Adam David, MD

Dr. David practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. David's NPI, 1437416054, was assigned on April 19, 2012. Dr. David holds Nebraska license 32850.

Dr. David's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. David also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. David's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. David is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. David practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. David's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. David's licenses on file in 2 states: Nebraska and Georgia.

CMS data shows 441 Medicare services from Dr. David across 11 procedure codes in 2024, for 204 Medicare patients. Medicare paid $24,638 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. David in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. David's median patient age at 72, with 26% women.

In 2024, Dr. David wrote 276 Medicare Part D claims for 96 patients. 97% of them were for generic drugs. CMS names the drug for 206 of them, across 5 drugs with 11 or more claims each, at $3,272 in total drug cost. In 2023, CMS named 241 claims across 8 drugs.

Dr. David accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. David as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. David, published from 2016 to 2024. 2016 was the busiest year, with 2. Dr. David's most frequent co-authors are Mehrdad E. Alemozaffar, Christopher Paul Filson, MD, MS and Salil D. Gabale, MD.

CMS Open Payments shows 50 general payments to Dr. David from 14 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $1,094.